{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:03:46Z","timestamp":1783699426400,"version":"3.55.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.msard.2019.101885","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:52:29Z","timestamp":1575460349000},"page":"101885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-5364","authenticated-orcid":false,"given":"Calle-Calle","family":"Raquel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triguero-Cueva","family":"Luc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valderrama-Mart\u00edn","family":"Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romero-Villarrubia","family":"Ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapia-G\u00f3mez","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquau-Lia\u00f1o","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnal-Garc\u00eda","family":"Carmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2019.101885_bib0001","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/14740338.2018.1483330","article-title":"Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis","volume":"17","author":"Buonomo","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.msard.2019.101885_bib0002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jinf.2006.04.013","article-title":"Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation","volume":"54","author":"Lim","year":"2007","journal-title":"J. Infect."},{"issue":"1","key":"10.1016\/j.msard.2019.101885_bib0003","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/504811","article-title":"Infectious complications associated with alemtuzumab use for lymphoproliferative disorders","volume":"43","author":"Martin","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.msard.2019.101885_bib0004","unstructured":"Rajesh, T.G.Toxoplasmosis in HIV-infected patients, 2019. https:\/\/www.uptodate.com\/contents\/toxoplasmosis-in-hiv-infected patients?search=toxoplasmosis20cerebral&source=search_result&selectedTitle=1~77&usage_type=default&display_rank=1#H7. Accessed June 4, 2019."},{"issue":"1","key":"10.1016\/j.msard.2019.101885_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.20453\/rmh.v11i1.630","article-title":"Toxoplasmosis cerebral en pacientes con SIDA en el Hospital Nacional Cayetano Heredia entre 1989 y 1999","volume":"11","author":"C\u00e1ceda","year":"2000","journal-title":"Rev Med Hered"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819309563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034819309563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:49:37Z","timestamp":1761900577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034819309563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":5,"alternative-id":["S2211034819309563"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2019.101885","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral toxoplasmosis in patient with relapsing-remitting multiple sclerosis under treatment with alemtuzumab","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2019.101885","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101885"}}